People diagnosed with headache had a greater risk for attempting and completing suicide, according to results of a cohort ...

However, we still see areas of weakness in the portfolio, including upcoming patent losses and a highly uncertain pipeline due to the complexities of running CNS trials. Historically, the firm ...

Headaches and migraine, including mild tension headaches, are linked to an increased risk of suicide, according to new ...

As Valentine's Day approaches, experts say that love might hold the key to a longer, healthier life. Uncover the unexpected ...

The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment of migraine with or without aura in adults.

Exploring Analgesics as a Key Painkiller Types & Their Role in Pain ReliefUnited States, New York, Feb. 04, 2025 (GLOBE ...

MAKE use of pharmacies and the services they can provide. Superdrug has just launched its new ear-wax removal service in 20 ...

People suffering from headaches, even if they are relatively mild, may be more prone to committing suicide, a study warns.

HEADACHES increase the odds of suicide, a new study says. While migraines and cluster headaches have already been linked to higher suicide risk, people with milder types, such as tension ...

The novel formulation of rizatriptan and meloxicam (Symbravo, Axome Therapeutics) is for the acute treatment of migraine with ...

The Axsome management team will provide an overview of SYMBRAVO and anticipated commercial plans. The presenters will be available to answer questions at the end of the presentation. To access the ...

Bristol Myers Squibb today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of Breyanzi® (lisocabtagene maraleucel; ...